UTHR FY 2020 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.5B+2.4% YoY

Gross Profit

$1.4B92.7% margin

Operating Income

$594M40.0% margin

Net Income

$515M34.7% margin

EPS (Diluted)

$11.54

Cash Flow

Operating Cash Flow

$756M

Free Cash Flow

$696M

Stock-Based Comp.

$164M

Balance Sheet

Total Assets

$4.6B

Total Liabilities

$1.2B

Stockholders' Equity

$3.4B

Cash & Equivalents

$739M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.4B	+2.4%
Gross Profit	$1.4B	$1.3B	+3.3%
Operating Income	$594M	-$188M	+416.4%
Net Income	$515M	-$105M	+592.6%